Risk Stratified Sequential Treatment for CD20-positive PTLD

Clinical trial NCT00590447 · COMPLETED

Trial details

NCT number: NCT00590447
Sponsor: Charite University, Berlin, Germany
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

PTLD Posttransplant Lymphoproliferative Disorder

Start date: 2006-12-01
Primary completion: 2014-12-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.